BioIntelliSense

Startup gets Army funding to test wearable monitor for early Covid-19 detection

Remote monitoring startup BioIntelliSense and Royal Phillips received $2.8 million to test BioIntelliSense’s device for the early detection of Covid-19 symptoms. The startup received FDA clearance for its small, adhesive monitoring device last year.